Journals / Türk Kardiyoloji Derneği Arşivi / 2012 / Cilt: 40 - Sayı: 5

Prediabetes, becoming the equivalent of coronary artery disease

Prediyabet koroner arter hastalığı eşdeğeri olma yolunda

Pages
458–465
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This review will focus on definition, detection, association with cardiovascular disease and treatment of prediabetes.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Prediabetes refers to a state where blood glucose levels are higher than normal, but not high enough to meet the diagnostic criteria for diabetes mellitus.
📊
Key Findings & Data:According to the Centers for Disease Control and Prevention data, 79 million individuals in the United States have prediabetes.
💡
Conclusion & Impact:This review will focus on definition, detection, association with cardiovascular disease and treatment of prediabetes.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Prediabetes refers to a state where blood glucose levels are higher than normal, but not high enough to meet the diagnostic criteria for diabetes mellitus. Similar to the worldwide trend, data derived from large studies has shown an increasing trend in the prevalence of prediabetes in Turkey. According to the Centers for Disease Control and Prevention data, 79 million individuals in the United States have prediabetes. This implies a large population worldwide is at risk of developing diabetes in the near future. In addition to its strong association with the development of diabetes, prediabetes itself represents an increased risk of developing cardiovascular disease and its complications. This review will focus on definition, detection, association with cardiovascular disease and treatment of prediabetes.

Özet

Prediyabet kan şekerinin normalden daha yüksek ancak, diyabet tanısı koyduracak düzeyden daha düşük olması şeklinde tanımlanır. Tüm dünyada olduğu gibi ülkemizde de yapılan geniş çalışmalarda prediyabet prevalansının belirgin bir artış eğilimi içinde olduğu görülmüştür. “Centers for Disease Control and Prevention” verilerine göre Amerika Birleşik Devletleri’nde 79 milyon prediyabetli hasta bulunmaktadır. Bu durum, tüm dünyada geniş bir popülasyonun yakın bir gelecekte diyabet gelişme riski altında olduğunu göstermektedir. Diyabet gelişimi ile olan güçlü ilişkisinin yanında, prediyabet kardiyovasküler hastalıkların ve komplikasyonlarının gelişme riskini artırmaktadır. Bu yazıda, prediyabetin tanımı, tespiti, kardiyovasküler hastalıklarla ilişkisi ve tedavisi tartışıldı.

🔖

Cite This Article

ALTUNKAŞ, F., CEYHAN, K. (2022). Prediabetes, becoming the equivalent of coronary artery disease. Türk Kardiyoloji Derneği Arşivi, Cilt: 40 - Sayı: 5, 458–465. https://ajindex.com/articles/633005

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. James C, Bullard KM, Rolka DB, Geiss LS, Williams DE, Cowie CC, et al. Implications of alternative definitions of prediabetes for prevalence in U.S. adults. Diabetes Care 2011;34:387-91
  2. Onat A. Türk erişkinlerinde diyabet ve prediyabet: Patogeneze önemli katkı. İçinde: Onat A, editör. Halkımızın kusurlu kalp sağlığına ışık yoluyla, tıbba büyük katkı. İstanbul: Logos Yayıncılık; 2011. s. 148-58
  3. Satman I, Yilmaz T, Sengul A, Salman S, Salman F, Uygur S, et al. Population-based study of diabetes and risk characteristics in Turkey: results of the turkish diabetes epidemiology study (TURDEP). Diabetes Care 2002;25:1551-6
  4. Satman I. Türkiye diyabet, hipertansiyon, obezite ve endokrinolojik hastalıklar prevalans çalışması-II (TURDEP-II). Türkiye Endokrinoloji ve Metabolizma Derneği resmi web sayfası: Türkiye Endokrinoloji ve Metabolizma Derneği; 2011
  5. Abdul-Ghani MA, Tripathy D, DeFronzo RA. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 2006;29:1130-9
  6. Diabetes mellitus. Report of a WHO expert committee. World Health Organization technical report series. 1965;310:1-44
  7. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes 1979;28:1039-57
  8. WHO Expert Committee on Diabetes Mellitus: second report. World Health Organization technical report series. 1980;646:1-80
  9. Borch-Johnsen K. IGT and IFG. Time for revision? Diabet Med 2002;19:707
  10. Engelgau MM, Thompson TJ, Herman WH, Boyle JP, Aubert RE, Kenny SJ, et al. Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited. Diabetes Care 1997;20:785-91
  11. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-97
  12. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-53
  13. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26 Suppl 1:S5-20
  14. Standards of medical care in diabetes-2010. Diabetes Care 2010;33 Suppl 1:S11-61
  15. Standards of medical care in diabetes-2011. Diabetes Care 2011;34 Suppl 1:S11-61
  16. Nathan DM, Davidson MB, De